Generating gametes from nonreproductive tissues could help overcome infertility. Previous studies have successfully ...

Boston Scientific Corp. continues to prove out its strategy of active acquisitions combined with industry-leading organic growth with the closing of its $88 million acquisition of Elutia Inc.’s ...

Caught between the start of fiscal 2026 and a congressional funding standoff that shut down much of the U.S. federal government Oct. 1, the FDA will not be able to collect 2026 user fees until ...

Patients with chronic spontaneous urticaria who remain symptomatic despite H1 antihistamine treatment now have a new oral treatment option, with the U.S. FDA’s approval of Novartis AG’s Rhapsido ...

AI seems to suggest that a world of problems with health care spending may become more manageable, but Stephen Bittinger, a shareholder in the D.C. office of the law firm of Polsinelli PC told ...

Ernst & Young LLP didn't quite declare the patient cured but saw signs of a strong med-tech recovery after a few years on ...

Roche Holdings AG reported results from its TSIX study which demonstrated that its sixth-generation Troponin T test is ...

Opus Genetics Inc. will be sitting down with the U.S. FDA to talk about positive three-month data from the pediatric cohort ...

The U.S. FDA’s early alert program has communicated a number of potential device malfunction episodes since its inception in ...

Anaptysbio Inc. said it intends to split into two publicly traded companies – one for developing a pipeline, the other for ...

Palmetto GBA, the Medicare administrative contractor for most of the southeastern U.S., has opened a coverage analysis for ...

Despite down-to-the-wire negotiations, the odds are that parts of the U.S. government will shut down at midnight Sept. 30, as ...